“…We used specific antibodies to the intracellular I-II loop on the NaCh ␣-subunit (aa 476 -485 of full length aa 1-2005; P04775), polyclonal rabbit anti-brain type II NaCh Ab (AB5206; 1:50; Chemicon, Temecula, CA) (Noda et al, 1986;Gordon et al, 1987;Westenbroek et al, 1989), and intracellular III-IV loop of the NaCh ␣-subunit (aa 1491-1508 of full length aa 1-2005; P04775), and polyclonal rabbit anti-pan NaCh Ab (06 -811; 1:80; Upstate Biotechnology) (Miller et al, 1983;DugandzijaNovakovic et al, 1995;Vabnick et al, 1996;Meier et al, 1997;Rasband et al, 1999) to evaluate immunoreactive changes with and without pharmacologic modulation. Treatment groups included control saline solution (CSS), TTX (Sigma), and a protease inhibitor (PI) mixture tablet Complete (Roche Diagnostics, Indianapolis, IN), which inhibits Ͼ90% of each protease activity of serine and cysteine (including calpain I and II) proteases, metalloproteases, Pronase, thermolysin, chymotrypsin, trypsin, and papain.…”